期刊文献+

XAV939对卵巢癌细胞增殖的抑制作用

Inhibitory effects of XAV939 on the proliferation of ovarian carcinoma cells
原文传递
导出
摘要 目的观察XAV939对卵巢癌细胞株OVCAR3增殖的作用。方法采用MTT法检测XAV939对卵巢癌细胞增殖的抑制作用,用流式细胞技术检测卵巢癌细胞株OVCAR3细胞周期和凋亡,Western blotting法检测Cyclin D1、Bcl-2的表达以及PARP剪切片段。结果 XAV939对卵巢癌细胞株增殖的抑制呈现浓度依赖性和时间依赖性,细胞周期检测表现为G1期阻滞,凋亡检测显示凋亡率增加。不同浓度的XAV939处理组的卵巢癌细胞Cyclin D1、Bcl-2蛋白表达水平下降,PARP剪切片段增多。结论 XAV939可以抑制卵巢癌细胞株OVCAR3的增殖。 Objective To investigate the effects of XAV939 on the proliferation of ovarian cancer OVCAR3 cells in vitro. Methods The OVCAR3 ovarian cancer cells were cultured with different concentrations of XAV939. The cell proliferation was detected by MTT method, cell cycle and apoptosis were determined by Flow cytometry, the expression of Cyclin D1 and Bcl-2 proteins and the level of PARP cleavage segment were detected by Western blot. Results XAV939 inhibited the proliferation of OVCAR3 ovarian cancer cells with dose- and time-dependent manner, inhibited the cell cycle at G1 phase, and increased the apoptosis rate of the cells, and downregulated the expression levels of Cyclin D1 and Bcl-2 proteins, and upregulated the level of PARP cleavage segment in OVCAR3 ovarian cancer cells. Conclusion XAV939 can inhibit the proliferation of OVCAR3 ovarian cancer cells.
出处 《解剖科学进展》 2015年第6期596-598,601,共4页 Progress of Anatomical Sciences
基金 国家自然科学基金(81202049 81472440)
关键词 XAV-939 卵巢癌细胞株OVCAR3 CYCLIN D1 BCL-2 PARP XAV939 ovarian cancer OVCAR3 cells cyclin D1 Bcl-2 PARP
  • 相关文献

参考文献17

  • 1Jayson GC,Kohn EC,Kitchener HC,et al.Ovarian cancer[J].Lancet,2014,384(9951):1376-1388.
  • 2Malanchil,Peinado H,Kassen D,et al.Cutaneous cancer stem cell maintenance is dependent oil beta-catenin signaling[J].Nature,2008,452(7187):650-653.
  • 3Sun X,He Y,Huang C,et al.Distinctive micm RNA signature associated of neoplasms with the Wnt/beta-catenin signaling pathway[J].Cell Signal,2013,25(12):2805-2811.
  • 4张鑫馨,邵淑丽.β-连环素及E-钙粘附素在上皮性卵巢肿瘤中的表达及临床意义[J].中国医疗前沿,2011,6(2):43-44. 被引量:5
  • 5Schmid S,Bieber M,Zhang F,et al.Wnt and hedgehog gene pathway expression in serous ovarian cancer[J].Int J Gynecol Cancer,2011,21(6):975-980.
  • 6Chau WK,Ip CK,Mak AS,et al.C-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/beta-catenin-ATP-bindiog cassette G2signaling[J].Oneogene,2013,32(22):2767-2781.
  • 7Huang SM,Mishina YM,Liu S,et al.Tankyrase inhibition stabilizes axin and antagonizes Wnt signaling[J].Nature,2009,461(7264):614-620.
  • 8Bao R,Christova T,Song S,et al.Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells[J].PLo S One,2012,7(11):48670.
  • 9何庆良,周俊峰,黄发昆,张琳,王家兴.XAV939对胃癌细胞株MKN-45的增殖及Wnt/β-连环蛋白信号通路的抑制作用[J].中华实验外科杂志,2014,31(12):2745-2747. 被引量:4
  • 10郭小荣,沈丹华,杜金荣.卵巢癌发病机制的研究进展[J].中华病理学杂志,2008,37(9):627-630. 被引量:9

二级参考文献70

  • 1于颖彦,朱正纲,严超,计俊,张俊,刘炳亚,燕敏,尹浩然,林言箴.胃癌与Wnt/β连环素信号通道活化的关系[J].中华实验外科杂志,2004,21(12):1557-1557. 被引量:12
  • 2邵汇琳,沈丹华,薛卫成,李艺,虞有智.卵巢上皮性肿瘤的临床病理特征及其细胞周期素D1和p53蛋白表达的研究[J].中华妇产科杂志,2007,42(4):227-232. 被引量:10
  • 3Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol, 2004,164(5) :1511-1518.
  • 4Smith Sehdev AE, Sehdev PS, Kurman RJ,et al. Noinvasive and invasive micropapillary serous carcinoma of the ovary: a clinicopathological analysis of 135 cases. Am J Surg Pathol, 2003, 27(6) :725-736.
  • 5McCluggage WG. My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol, 2008,61 (2) : 152-163.
  • 6Mok SC, Bell DA, Knapp RC, et al. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res, 1993,53 (7) : 1489-1492.
  • 7Shih IeM, Kurman RJ. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res, 2005,11 (20) :7273-7279.
  • 8Kumar R, Angelini S, Snellman E, et al. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol, 2004,122 (2) : 342-348.
  • 9Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature ,2002, 417(6892) :949-954.
  • 10Rajagopalan H, Bardelli A, Lengauer C, et al. Tumorigenesis: RAF/RAS oncogenes and mismatchrepair status. Nature,2002, 418(6901) :934.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部